These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 4606368

  • 1. Comparative trial of pancrex V forte and nutrizym in treatment of malabsorption in cystic fibrosis.
    Goodchild MC, Sagaró E, Brown GA, Cruchley PM, Jukes HR, Anderson CM.
    Br Med J; 1974 Sep 21; 3(5933):712-4. PubMed ID: 4606368
    [Abstract] [Full Text] [Related]

  • 2. Comparative trial of Nutrizym in chronic pancreatic insufficiency.
    Knill-Jones RP, Pearce H, Batten J, Williams R.
    Br Med J; 1970 Oct 03; 4(5726):21-4. PubMed ID: 4919118
    [Abstract] [Full Text] [Related]

  • 3. [Comparative double blind experience of a polyenzymatic preparation in chronic pancreatic insufficiency (author's transl)].
    Knill-Jones RP, Batten PJ, Williams R.
    Acta Gastroenterol Belg; 1973 Sep 03; 36(9):489-504. PubMed ID: 4589486
    [No Abstract] [Full Text] [Related]

  • 4. Assessment of adequacy of pancreatic enzyme replacement with the multiple-phase carbon-14-triolein test.
    O'Keefe SJ, Adam J.
    S Afr Med J; 1984 Nov 17; 66(20):763-5. PubMed ID: 6208620
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Comparison of four pancreatic extracts in cystic fibrosis.
    Beverley DW, Kelleher J, MacDonald A, Littlewood JM, Robinson T, Walters MP.
    Arch Dis Child; 1987 Jun 17; 62(6):564-8. PubMed ID: 3304172
    [Abstract] [Full Text] [Related]

  • 8. Gut inflammation in children with cystic fibrosis on high-dose enzyme supplementation.
    Doull I, Langton-Hewer S.
    Lancet; 1996 Feb 03; 347(8997):327. PubMed ID: 8569382
    [No Abstract] [Full Text] [Related]

  • 9. Faecal bile acid and dietary residue excretion in cystic fibrosis: age group variations.
    Walters MP, Littlewood JM.
    J Pediatr Gastroenterol Nutr; 1998 Sep 03; 27(3):296-300. PubMed ID: 9740200
    [Abstract] [Full Text] [Related]

  • 10. The use of L-arginine and sodium bicarbonate in the treatment of malabsorption due to cystic fibrosis.
    Kattwinkel J, Agus SG, Taussig LM, Di Sant'Agnese PA, Laster L.
    Pediatrics; 1972 Jul 03; 50(1):133-7. PubMed ID: 5038088
    [No Abstract] [Full Text] [Related]

  • 11. Fat malabsorption in cystic fibrosis patients receiving enzyme replacement therapy is due to impaired intestinal uptake of long-chain fatty acids.
    Kalivianakis M, Minich DM, Bijleveld CM, van Aalderen WM, Stellaard F, Laseur M, Vonk RJ, Verkade HJ.
    Am J Clin Nutr; 1999 Jan 03; 69(1):127-34. PubMed ID: 9925134
    [Abstract] [Full Text] [Related]

  • 12. Study of a novel pancreatic enzyme replacement therapy in pancreatic insufficient subjects with cystic fibrosis.
    Borowitz D, Goss CH, Limauro S, Konstan MW, Blake K, Casey S, Quittner AL, Murray FT.
    J Pediatr; 2006 Nov 03; 149(5):658-662. PubMed ID: 17095338
    [Abstract] [Full Text] [Related]

  • 13. [Study with a test meal of the effect of a choleratic (Moquizone) combined with digestive enzymes].
    Sarti F, Toscano S.
    G Clin Med; 1974 Oct 03; 55(10):732-8. PubMed ID: 4465149
    [No Abstract] [Full Text] [Related]

  • 14. Systematic review: pancreatic enzyme treatment of malabsorption associated with chronic pancreatitis.
    Waljee AK, Dimagno MJ, Wu BU, Schoenfeld PS, Conwell DL.
    Aliment Pharmacol Ther; 2009 Feb 01; 29(3):235-46. PubMed ID: 19035969
    [Abstract] [Full Text] [Related]

  • 15. Comparison of effectiveness of pancreatic enzyme preparations in cystic fibrosis.
    Mischler EH, Parrell S, Farrell PM, Odell GB.
    Am J Dis Child; 1982 Dec 01; 136(12):1060-3. PubMed ID: 7148760
    [Abstract] [Full Text] [Related]

  • 16. Effect of taurine supplementation on fat and energy absorption in cystic fibrosis.
    De Curtis M, Santamaria F, Ercolini P, Vittoria L, De Ritis G, Garofalo V, Ciccimarra F.
    Arch Dis Child; 1992 Sep 01; 67(9):1082-5. PubMed ID: 1417050
    [Abstract] [Full Text] [Related]

  • 17. Liprotamase long-term safety and support of nutritional status in pancreatic-insufficient cystic fibrosis.
    Borowitz D, Stevens C, Brettman LR, Campion M, Wilschanski M, Thompson H, Liprotamase 767 Study Group.
    J Pediatr Gastroenterol Nutr; 2012 Feb 01; 54(2):248-57. PubMed ID: 22266487
    [Abstract] [Full Text] [Related]

  • 18. A comparison of two pancreatin microsphere preparations in cystic fibrosis.
    Elliott RB, Escobar LC, Lees HR, Akroyd RM, Reilly HC.
    N Z Med J; 1992 Mar 25; 105(930):107-8. PubMed ID: 1553114
    [Abstract] [Full Text] [Related]

  • 19. [Comparative study of the effect of kreon and cotazyme forte in children with cystic fibrosis].
    Zsíros J, Sólyom E.
    Orv Hetil; 1988 May 08; 129(19):995-9. PubMed ID: 3290773
    [No Abstract] [Full Text] [Related]

  • 20. International phase III trial of liprotamase efficacy and safety in pancreatic-insufficient cystic fibrosis patients.
    Borowitz D, Stevens C, Brettman LR, Campion M, Chatfield B, Cipolli M, Liprotamase 726 Study Group.
    J Cyst Fibros; 2011 Dec 08; 10(6):443-52. PubMed ID: 21831726
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.